Nappi 1997.
Methods | multicentre, double blind, randomized, placebo controlled, parallel groups | |
Participants | SDAT or MID mild to moderate; 51patients received nicergoline, 50 placebo; age 60‐80 yr. | |
Interventions | Nicergoline or Placebo 30mg. twice a day (os) for 12 months | |
Outcomes | SCAG, MMSE, CGI for efficacy; adverse events for safety | |
Notes |